Total Payments
$7,595
2024 Payments
$5,534
Companies
12
Transactions
29
Medicare Patients
1,851
Medicare Billing
$616,925
Payment Breakdown by Category
Consulting$4,700 (61.9%)
Food & Beverage$2,516 (33.1%)
Travel$281.00 (3.7%)
Education$97.99 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,700 | 2 | 61.9% |
| Food and Beverage | $2,516 | 25 | 33.1% |
| Travel and Lodging | $281.00 | 1 | 3.7% |
| Education | $97.99 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $5,238 | 5 | $0 (2024) |
| LENSAR, Inc. | $650.45 | 1 | $0 (2021) |
| Genentech USA, Inc. | $390.07 | 5 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $261.44 | 3 | $0 (2024) |
| Genentech, Inc. | $242.14 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $220.53 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $204.67 | 2 | $0 (2023) |
| Allergan, Inc. | $144.57 | 2 | $0 (2021) |
| Alimera Sciences, Inc. | $110.96 | 2 | $0 (2024) |
| Alcon Laboratories Inc | $69.16 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,534 | 9 | Regeneron Pharmaceuticals, Inc. ($5,112) |
| 2023 | $846.15 | 10 | Genentech USA, Inc. ($295.26) |
| 2022 | $351.41 | 5 | Apellis Pharmaceuticals, Inc. ($136.44) |
| 2021 | $697.03 | 2 | LENSAR, Inc. ($650.45) |
| 2018 | $69.16 | 2 | Alcon Laboratories Inc ($69.16) |
| 2017 | $97.99 | 1 | Allergan Inc. ($97.99) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,820.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $281.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $108.33 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $76.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/14/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $131.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 02/21/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $85.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 02/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Ophthalmology | ||||||
| 10/26/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/04/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $119.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/23/2023 | Genentech, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/15/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: EYE CARE | ||||||
| 07/13/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $112.20 | General |
| 05/31/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $123.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/04/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $144.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/12/2023 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/06/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $125.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/08/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/29/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.44 | General |
| 11/08/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 11/01/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $85.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/10/2022 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 02/22/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $94.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/04/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $46.58 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,255 | 10,548 | $1.9M | $532,612 |
| 2022 | 11 | 401 | 572 | $304,374 | $70,093 |
| 2021 | 6 | 154 | 158 | $303,122 | $11,828 |
| 2020 | 2 | 41 | 41 | $12,675 | $2,392 |
Total Patients
1,851
Total Services
11,319
Medicare Billing
$616,925
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 26 | 7,801 | $1.0M | $219,692 | 21.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 53 | 222 | $319,300 | $141,041 | 44.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 136 | 539 | $204,290 | $54,356 | 26.6% |
| 92134 | Imaging of retina | Office | 2023 | 341 | 874 | $89,148 | $29,236 | 32.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 104 | 389 | $97,250 | $27,990 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 244 | $76,860 | $24,317 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 208 | 310 | $68,820 | $21,783 | 31.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 43 | 43 | $11,907 | $4,992 | 41.9% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 16 | $19,888 | $3,272 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,361 | $2,218 | 23.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 18 | 18 | $5,652 | $1,341 | 23.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 22 | 31 | $7,161 | $1,226 | 17.1% |
| 92250 | Photography of the retina | Office | 2023 | 38 | 38 | $6,232 | $1,148 | 18.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 14 | 46 | $68,200 | $31,214 | 45.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 52 | 92 | $32,550 | $9,062 | 27.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 34 | 70 | $17,500 | $5,159 | 29.5% |
| 92134 | Imaging of retina | Office | 2022 | 92 | 143 | $14,560 | $4,679 | 32.1% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 16 | 16 | $63,974 | $4,420 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 38 | $11,872 | $3,859 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 52 | $11,472 | $3,750 | 32.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 23 | 23 | $5,175 | $2,460 | 47.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 22 | 22 | $6,908 | $2,137 | 30.9% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 12 | 13 | $59,848 | $1,327 | 2.2% |
| 67028 | Injection of drug into eye | Facility | 2022 | 15 | 16 | $7,125 | $1,064 | 14.9% |
| 92250 | Photography of the retina | Office | 2022 | 22 | 22 | $3,496 | $607.69 | 17.4% |
About Joseph Simonett
Joseph Simonett is a Ophthalmology healthcare provider based in Milwaukie, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1770972440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Simonett has received a total of $7,595 in payments from pharmaceutical and medical device companies, with $5,534 received in 2024. These payments were reported across 29 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($4,700).
As a Medicare-enrolled provider, Simonett has provided services to 1,851 Medicare beneficiaries, totaling 11,319 services with total Medicare billing of $616,925. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Milwaukie, OR
- Active Since 01/17/2015
- Last Updated 12/29/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1770972440
Products in Payments
- EYLEA HD (Biological) $5,232
- LENSAR LASER SYSTEM (Device) $650.45
- Vabysmo (Drug) $387.40
- EYLEA (Biological) $210.72
- Susvimo (Drug) $150.00
- Syfovre (Drug) $125.00
- Izervay (Drug) $108.33
- VABYSMO (Drug) $94.81
- ILUVIEN (Drug) $85.00
- OZURDEX (Drug) $74.86
- AcrySof (Device) $69.16
- YUTIQ (Drug) $60.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.